ACAD stock news

As of late, it has definitely been a great time to be an investor in ACADIA Pharmaceuticals Inc. (ACAD). Read more
Acadia (ACAD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Read more
Acadia Pharmaceuticals Inc. shares dropped in the extended session Monday after the biotech drug maker said its schizophrenia treatment did not pass a… Read more
The contentious drug-pricing debate weighed on Acadia Pharmaceuticals' shares last month. Read more
ACAD earnings call for the period ending March 31, 2019. Read more
Acadia (ACAD) delivered earnings and revenue surprises of -9.26% and 6.17%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock? Read more

ACADIA Pharma misses by $0.07, beats on revenue

08:10pm, Wednesday, 01'st May 2019
ACADIA Pharma (ACAD): Q1 GAAP EPS of -$0.59 misses by $0.07. Revenue of $63M (+28.9% Y/Y) beats by $2.07M. Press Release Read more

ACADIA Pharma Q1 Earnings Preview

09:35pm, Tuesday, 30'th Apr 2019
Read more
Acadia (ACAD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Read more
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)’s shares are under review with key ownership changing hands of late. As company earnings reports continue to roll in, investors will be watching to see whic Read more
Stock market investors might be taking note of recent trends. Many investors will be digging deep into the numbers to try and spot potential breakouts. Following the numbers for ACADIA Pharmaceuticals Read more
Keen investors are consistently searching for true bargains in the stock market. Finding these stocks can make the difference between a winning or losing portfolio. Shares of ACADIA Pharmaceuticals In Read more
We will be comparing the differences between ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) and Concert Pharmaceuticals Inc. (NASDAQ:CNCE) as far as risk, analyst recommendations, institutional ownership, Read more

Proudly made at

ROCKIT